URIFIND
Live / Registered — Registered (as of 24 Oct 2023)
What this means for you
Registered since 24 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90030700
- Registration number
- 7202367
- Mark type
- Word mark
- Filed
- 01 Jul 2020
- Published for opposition
- 15 Jun 2021
- Registered
- 24 Oct 2023
- Attorney of record
- Timothy T. Wang
Goods and services
- Class 005 — Pharmaceuticals: diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for tumor therapy; organotherapy preparations; biological tissue cultures for medical purposes; medicine for tumor therapy; radioactive substances for medical purposes; media for bacteriological cultures; dietetic preparations adapted for medical purposes, namely, dietetic substances adapted for adjuvant therapy of tumors; wadding for medical purposes
- Class 010 — Medical apparatus: medical apparatus and instruments for diagnosing and therapeutic treatment of tumors; medical apparatus and instruments for diagnosing urological conditions, namely, urological apparatus and instruments, for IVD (in vitro diagnosis); medical diagnostic apparatus for testing nucleic acids and proteins, all for medical purposes; dialyzers; apparatus for DNA and RNA testing for medical purposes; enema apparatus for medical purposes; surgical apparatus and instruments; urethral probes
Owner
- AnchorDx Medical Co., Ltd., Guangzhou, CN
- AnchorDx Medical Co., Ltd., Guangzhou, CN
- AnchorDx Medical Co., Ltd., Guangzhou, CN
Prosecution history
- 24 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 21 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Sept 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Apr 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Apr 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Apr 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Apr 2023 — NON-FINAL ACTION E-MAILED
- 03 Apr 2023 — SU - NON-FINAL ACTION - WRITTEN
- 04 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Feb 2023 — USE AMENDMENT FILED
- 27 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL